++
+++
General Considerations
++
Unintended pregnancies are a worldwide problem but disproportionately impact developing countries
There were 121 million unintended pregnancies annually from 2015 to 2019, corresponding to a global rate of 64 per 1000 women aged 15–49
Globally, 61% ended in abortion
Primary care providers need to educate their patients about the benefits of contraception and to provide them options that are appropriate and desirable
++
Combination pills
Have a theoretical failure rate of only 0.3% if taken absolutely on schedule but a typical use failure rate of 8%
Primary mode of action is suppression of ovulation
Pills can be started on the first day of the menstrual cycle, on the first Sunday after the onset of the cycle, or on any day of the cycle
If started on any day other than the first day of the cycle, a backup contraceptive method should be used
The combination pill is taken daily for 21 days, followed by 7 days of placebos or no medication, and this schedule is continued for each cycle
Pills are typically packaged in 21- or 28-day cyclic regimens but may be taken continuously to allow the user to decide if and when she wants a withdrawal bleed
Studies have not shown any significant risk from long-term amenorrhea for patients taking this continuous oral contraceptive regimen
Benefits
Selection
Any of the "low-dose" combination oral contraceptives (containing 35 mcg or less of ethinyl estradiol or 3 mg of estradiol valerate) are suitable for most women
There is some variation in potency of the various progestins in the low-dose pills, but this variation results in essentially no clinically significant differences for most women
Women who have acne or hirsutism may benefit from use of one of the pills containing the third-generation progestins, desogestrel or norgestimate, since they are the least androgenic
The low-dose oral contraceptives commonly used in the United States are listed in Table 18–2
Drug interactions
Drugs that interact with oral contraceptives potentially decreasing their efficacy include
Women taking these drugs should use another means of contraception for maximum protection
Antiretroviral medications, specifically ritonavir-boosted protease inhibitors, may significantly decrease the efficacy of combined oral contraceptives, and the concomitant use of oral contraceptives may increase the toxicity of these antiretroviral agents
Non-nucleoside reverse transcriptase inhibitors have smaller effects on oral contraceptive efficacy, while nucleoside reverse ...